Ibragimova, K. I. E., Geurts, S. M. E., Croes, S., Erdkamp, F., Heijns, J. B., Tol, J., . . . Tjan-Heijnen, V. C. G. (2021). Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry. Breast Cancer Res Treat.
Citação norma ChicagoIbragimova, Khava I. E., et al. "Survival Before and After the Introduction of Pertuzumab and T-DM1 in HER2-positive Advanced Breast Cancer, a Study of the SONABRE Registry." Breast Cancer Res Treat 2021.
Citação norma MLAIbragimova, Khava I. E., et al. "Survival Before and After the Introduction of Pertuzumab and T-DM1 in HER2-positive Advanced Breast Cancer, a Study of the SONABRE Registry." Breast Cancer Res Treat 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.